CEREBRAL VENOSUS SINUS THROMBOSIS IN A HEALTHY WOMEN TAKING ORAL CONTRACEPTIVE: A CASE REPORT AND REVIEW OF LITERATURE

Kamuran Suman, B. P. Goksedef, B. Koç
{"title":"CEREBRAL VENOSUS SINUS THROMBOSIS IN A HEALTHY WOMEN TAKING ORAL CONTRACEPTIVE: A CASE REPORT AND REVIEW OF LITERATURE","authors":"Kamuran Suman, B. P. Goksedef, B. Koç","doi":"10.5505/TJOD.2013.83604","DOIUrl":null,"url":null,"abstract":"SUMMARY Cerebral venous sinus thrombosis (CVST) is rare than arterial thrombosis. It can affect all age groups but is seen mostly in young women. The diagnosis of CVST is not easy because of variability of clinical symptoms and signs. The patients can present with headache, papilledema, focal deficit, seizures and coma. The most frequent symptom is severe headache. The most common causes of CVST are pregnancy, puerperium, systemic inflammatory diseases, inherited and acquired coagulation disorders, trauma, lumbar puncture, drugs and infection. The use of oral contraceptive (OC) increases the risk of cerebral sinus thrombosis. If there is an additional hereditary prothrombotic factor, the risk of CVST is more. CVST affects superior sagittal sinus and the lateral sinuses more frequently. More than one sinus is affected in one-third of cases. Computed tomografi helps to exclude other intracranial condition but diagnostic value of CT in CVST is limited. Combination of magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) have replaced cerebral angiography for diagnosis of CVST. The treatment of CVST contain supportive (hydration, antibiotheraphy, anticonvulsant) and anticoagulan treatment. Heparin is effective and safety for the treatment of CVST because of this, it is the first-line treatment. The safety of heparin treatment also has been shown in those patients who had hemorrhagic infarcts. Outcomes of CVST is variable from death to complete improvement, but in general it is favorable. Recurrence of CVT is not common. Herein we present a 33-years old previously healthy women with CVST who taking OC.","PeriodicalId":174635,"journal":{"name":"Journal of Turkish Society of Obstetric and Gynecology","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Turkish Society of Obstetric and Gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5505/TJOD.2013.83604","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

SUMMARY Cerebral venous sinus thrombosis (CVST) is rare than arterial thrombosis. It can affect all age groups but is seen mostly in young women. The diagnosis of CVST is not easy because of variability of clinical symptoms and signs. The patients can present with headache, papilledema, focal deficit, seizures and coma. The most frequent symptom is severe headache. The most common causes of CVST are pregnancy, puerperium, systemic inflammatory diseases, inherited and acquired coagulation disorders, trauma, lumbar puncture, drugs and infection. The use of oral contraceptive (OC) increases the risk of cerebral sinus thrombosis. If there is an additional hereditary prothrombotic factor, the risk of CVST is more. CVST affects superior sagittal sinus and the lateral sinuses more frequently. More than one sinus is affected in one-third of cases. Computed tomografi helps to exclude other intracranial condition but diagnostic value of CT in CVST is limited. Combination of magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) have replaced cerebral angiography for diagnosis of CVST. The treatment of CVST contain supportive (hydration, antibiotheraphy, anticonvulsant) and anticoagulan treatment. Heparin is effective and safety for the treatment of CVST because of this, it is the first-line treatment. The safety of heparin treatment also has been shown in those patients who had hemorrhagic infarcts. Outcomes of CVST is variable from death to complete improvement, but in general it is favorable. Recurrence of CVT is not common. Herein we present a 33-years old previously healthy women with CVST who taking OC.
服用口服避孕药的健康妇女脑静脉窦血栓形成一例报告及文献复习
脑静脉窦血栓形成(CVST)较动脉血栓形成少见。它可以影响所有年龄组,但主要见于年轻女性。由于临床症状和体征的多变性,CVST的诊断并不容易。患者可表现为头痛、乳头水肿、局灶性缺陷、癫痫发作和昏迷。最常见的症状是严重的头痛。CVST最常见的原因是妊娠、产褥期、全身性炎症疾病、遗传和获得性凝血功能障碍、创伤、腰椎穿刺、药物和感染。口服避孕药(OC)的使用增加了脑窦血栓形成的风险。如果有一个额外的遗传性血栓形成因子,CVST的风险更大。CVST更常影响上矢状窦和侧窦。在三分之一的病例中,不止一个鼻窦受到影响。CT有助于排除其他颅内疾病,但CT对CVST的诊断价值有限。磁共振成像(MRI)和磁共振静脉造影(MRV)的结合已取代脑血管造影诊断CVST。CVST的治疗包括支持治疗(水合、抗生素治疗、抗惊厥药)和抗凝治疗。肝素治疗CVST有效且安全,因此是一线治疗。肝素治疗的安全性也已在出血性梗死患者中得到证实。从死亡到完全改善,CVST的结果是可变的,但总的来说是有利的。CVT复发并不常见。在此,我们报告了一名33岁既往健康的CVST女性服用OC。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信